Protective activity of hydroalcoholic extract of zingiber officinale rosc. on doxorubicin-induced hepatic toxicity in male rats
Open Access
- 1 July 2023
- journal article
- Published by Apex Publishing in Medical Laboratory Journal
- Vol. 17 (4) , 9-12
Abstract
Marzieh Niakan1 , Habib Alla Johari 2, Mehrdad Shariati1 , Davood Moghadamnia3 , Ebrahim Talebi4 Background: Research has shown that the extract of some plants has an effective protective effect on liver cells against toxins and oxidants. In this research, the effect of hydroalcoholic extract of ginger against hepatotoxicity caused by doxorubicin (Dox) ...Keywords
This publication has 32 references indexed in Scilit:
- Ginger (Zingiber officinaleRosc.) and its bioactive components are potential resources for health beneficial agentsPhytotherapy Research, 2020
- Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathwaysBiomedicine & Pharmacotherapy, 2020
- Protective effect of ginger (Zingiber officinale) against PCB-induced acute hepatotoxicity in male ratsRSC Advances, 2019
- Doxorubicin treatments induce significant changes on the cardiac autonomic nervous system in childhood acute lymphoblastic leukemia long-term survivorsClinical Research in Cardiology, 2019
- Histological study of the protective role of ginger on piroxicam-induced liver toxicity in miceJournal of the Chinese Medical Association, 2019
- Dual protective effect of ginger and rosemary extracts against CCl4-induced hepatotoxicity in ratsEnvironmental Science and Pollution Research, 2018
- Zingiber officinale and 6-gingerol alleviate liver and kidney dysfunctions and oxidative stress induced by mercuric chloride in male rats: A protective approachBiomedicine & Pharmacotherapy, 2017
- Histopathology Procedures: From Tissue Sampling to Histopathological Evaluation2010
- Increased expression of multidrug resistance‐associated proteins in bladder cancer during clinical course and drug resistance to doxorubicinInternational Journal of Cancer, 2002
- Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazineBritish Journal of Cancer, 2000